Literature DB >> 6831833

Serum concentration and renal excretion by normal adults of inorganic sulfate after acetaminophen, ascorbic acid, or sodium sulfate.

M E Morris, G Levy.   

Abstract

Depletion of endogenous inorganic sulfate can have pronounced effects on the elimination kinetics and metabolic fate of phenolic drugs. Our purpose was to determine the effects of acetaminophen (which is partly metabolized to acetaminophen sulfate), ascorbic acid (subject to more limited sulfation than acetaminophen), and sodium sulfate (useful for sulfate repletion by the oral route) on the serum concentration and renal excretion of inorganic sulfate in healthy adults. Six men and two women, 26 to 35 yr old, were studied on four occasions that were at least 4 days apart. They received no medication, 1.5 gm acetaminophen, 6 gm ascorbic acid, or 9 gm sodium sulfate decahydrate orally, in aqueous solution. A blood sample was obtained 2 hr later and urine was collected from 1 to 3 hr. Serum inorganic sulfate concentrations (mean +/- SD), 0.410 +/- 0.043 mM in the control period, were decreased after acetaminophen (0.311 +/- 0.043 mM, P less than 0.001), increased after sodium sulfate (0.513 +/- 0.055 mM, P less than 0.001), and apparently unchanged after ascorbic acid (0.417 +/- 0.059 mM). The urinary excretion of inorganic sulfate was decreased after acetaminophen and increased after sodium sulfate. The renal clearance of endogenous creatinine was not affected by any of the treatments. The renal tubular reabsorption of inorganic sulfate is capacity limited, as evidenced by the decrease of the reabsorbed fraction with increasing glomerular filtration rate of the anion (r = -0.54, P less than 0.005). This saturable reabsorption facilitates sulfate homeostasis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6831833     DOI: 10.1038/clpt.1983.72

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  18 in total

Review 1.  Structure, dynamics and selectivity in the sulfotransferase family.

Authors:  Thomas S Leyh; Ian Cook; Ting Wang
Journal:  Drug Metab Rev       Date:  2013-09-11       Impact factor: 4.518

2.  Reduced sulfate plasma concentrations in the BTBR T+tf/J mouse model of autism.

Authors:  Michael J Corley; Ksenia Z Meyza; D Caroline Blanchard; Robert J Blanchard
Journal:  Physiol Behav       Date:  2012-04-17

3.  Decrease of inorganic blood sulfate following treatment with selected antirheumatic drugs: potential consequence for articular cartilage.

Authors:  B J de Vries; P M van der Kraan; W B van den Berg
Journal:  Agents Actions       Date:  1990-03

4.  Intestinal effects of sulfate in drinking water on normal human subjects.

Authors:  W D Heizer; R S Sandler; E Seal; S C Murray; M G Busby; B G Schliebe; S N Pusek
Journal:  Dig Dis Sci       Date:  1997-05       Impact factor: 3.199

5.  Effects of drug-mediated serum sulfate depletion on glycosaminoglycan synthesis.

Authors:  P M van der Kraan; B J de Vries; W B van den Berg; E Vitters; L B van de Putte
Journal:  Agents Actions       Date:  1988-02

6.  Sulfate homeostasis. IV. Probenecid-induced alterations of inorganic sulfate in rats.

Authors:  I M Darling; M E Morris
Journal:  Pharm Res       Date:  1991-03       Impact factor: 4.200

7.  Sulfate homeostasis. II. Influence of chronic aspirin administration on inorganic sulfate in humans.

Authors:  M E Morris; L J Benincosa
Journal:  Pharm Res       Date:  1990-07       Impact factor: 4.200

8.  Paracetamol interaction with oral contraceptive steroids: increased plasma concentrations of ethinyloestradiol.

Authors:  S M Rogers; D J Back; P J Stevenson; S F Grimmer; M L Orme
Journal:  Br J Clin Pharmacol       Date:  1987-06       Impact factor: 4.335

9.  The effect of acetaminophen administration on its disposition and body stores of sulphate.

Authors:  S Hendrix-Treacy; S M Wallace; K W Hindmarsh; G M Wyant; A Danilkewich
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

10.  Extracellular Cl(-) regulates human SO4 (2-)/anion exchanger SLC26A1 by altering pH sensitivity of anion transport.

Authors:  Meng Wu; John F Heneghan; David H Vandorpe; Laura I Escobar; Bai-Lin Wu; Seth L Alper
Journal:  Pflugers Arch       Date:  2016-04-29       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.